Older women with early stage breast cancer may not need radiotherapy after undergoing surgery, McMaster University researcher Timothy Whelan and his team has found.
Jun 7, 2022
0
2
In work presented at the 2022 EULAR Congress, Dr. Jens Kristian Pedersen and colleagues used data from the DANBIO registry to describe the all-cause mortality risk associated with depression in patients with incident rheumatoid ...
Jun 3, 2022
0
3
Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and ...
Jun 2, 2022
0
14
Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients ...
May 25, 2022
0
25
Culturally tailored lifestyle coaching can help Black adults with hypertension improve their blood pressure control, new Kaiser Permanente research shows. Improving blood pressure control is key to reducing risk for stroke, ...
May 18, 2022
0
0
Patients with chronic obstructive pulmonary disease (COPD) are more likely to have coronary heart disease (CHD), but no specific phenotypes have a higher risk, according to a study published online April 27 in PLOS ONE.
May 17, 2022
0
9
The Biden administration announced plans on April 26, 2022, to increase the availability of the COVID-19 drug Paxlovid, vowing to get more of the treatment pills into the hands of Americans.
Apr 29, 2022
0
10
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation. The research appeared April 22 in the journal JCI Insight.
Apr 26, 2022
0
42
Newly infected COVID-19 patients have two treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.
Apr 26, 2022
0
19
The U.S. Food and Drug Administration on Tuesday approved the antiviral remdesivir as the first COVID-19 treatment for young children.
Apr 26, 2022
0
5
